Food News and Research

RSS

Effectiveness of influenza vaccines in older people: No clear conclusions

Evidence for the safety and efficacy of influenza vaccines in the over 65s is poor, despite the fact that vaccination has been recommended for the prevention of influenza in older people for the past 40 years. These are the conclusions of a new Cochrane Systematic Review.

17 Feb 2010

U.S. decreases troop presence in Haiti

A decreased need for troops has led the U.S. military to reduce its troops from a high of about 20,000 after the earthquake to 13,000, General Douglas Fraser said on Saturday, Agence France-Presse reports. Fraser also said the Haitian government was resuming control of the Port-au-Prince airport during daylight, according to the AFP.

17 Feb 2010

Covidien's Exalgo NDA: FDA sets new PDUFA action date

Covidien today announced that the U.S. Food and Drug Administration has set a new action date of March 1, 2010, under the Prescription Drug User Fee Act (PDUFA) for the review of the New Drug Application (NDA) for Exalgo™ (hydromorphone HCl) Extended-Release Tablets, (CII).

17 Feb 2010

Covidien, IAE POLATOM announce agreement to augment supply of Mo 99 to produce Tc 99m

Covidien, a leading global provider of healthcare products, and the Institute of Atomic Energy in Poland today announced an agreement to augment and further diversify Covidien’s supply of Molybdenum 99 (Mo 99) to produce the medical isotope Technetium 99m (Tc 99m).

17 Feb 2010

FDA approves risk management program on ESA's for treating anemia due to chemotherapy

The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs). For patients with cancer, the program is also designed to help ensure the appropriate administration of these drugs, which they receive to treat anemia that can occur as a result of chemotherapy.

17 Feb 2010

NASBE selects four states to receive grants to fight childhood obesity in their public schools

The National Association of State Boards of Education, with support from the Robert Wood Johnson Foundation as part of its Leadership for Healthy Communities (LHC) national program, will select four states to receive grants this spring to help them develop policies to fight childhood obesity in their public schools.

17 Feb 2010

Iowa State University researchers awarded 30 ARRA grants worth $16.38M

Iowa State University researchers have so far won 30 grants worth a total $16.38 million from federal agencies awarding money from the American Recovery and Reinvestment Act (ARRA).

17 Feb 2010

New report focuses on how to reduce and control hypertension

High blood pressure is the second leading cause of death in the United States, triggering more than one-third of heart attacks and almost half of heart failures each year even though it is relatively easy to prevent and inexpensive to treat.

17 Feb 2010

In naming Islamic Conference Envoy, Obama highlights global health, food security efforts

During a video address to the 7th U.S.-Islamic World Forum meeting in Doha, Qatar, on Saturday, President Barack Obama appointed Rashad Hussain, deputy associate White House counsel, to serve as Special Envoy to the Organization of the Islamic Conference (OIC), the Associated Press reports.

17 Feb 2010

USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection

EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing acute-care hospital products, today announced that the US Patent and Trademark Office has issued two new patents covering methods of treatment and methods of preparation for the Company’s Ready-to-Use (RTU) Cardene® I.V. (nicardipine hydrochloride) Premixed Injection.

17 Feb 2010

Calypso real-time tumor tracking system usage during IMRT for prostate cancer reduces rectal/urinary side effects

Calypso Medical Technologies, Inc., a developer of targeting technology used for accurate, precise real-time tracking of tumor targets, today announced the online publication of a clinical study in Urology (The GOLD JOURNAL). The prospective, multi-site study, entitled, “Assessing the Impact of Margin Reduction (AIM),” is the first outcomes-based study to evaluate the quality of life of high-dose intensity-modulated radiotherapy (IMRT) to the prostate with tightly contoured treatment technically described as “reduced treatment margins.”

17 Feb 2010

High-fat ketogenic diet safe and effective for controlling childhood seizures

Current and former patients treated with the high-fat ketogenic diet to control multiple, daily and severe seizures can be reassured by the news that not only is the diet effective, but it also appears to have no long-lasting side effects, say scientists at Johns Hopkins Children's Center.

17 Feb 2010

Generx clinical development opportunities: bioRASI to assist Cardium

Cardium Therapeutics today announced that it has entered into an agreement with bioRASI, an international contract research organization, to assist Cardium in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures.

17 Feb 2010

Rhubarb may have anti-cancer properties, but more research needed

Rhubarb contains natural chemicals called polyphenols that have been shown to kill cancer cells in the lab, or prevent their growth. Baking appears to greatly increase the levels of these chemicals, UK scientists have found, but Cancer Research UK cautioned against reading too much into these results.

17 Feb 2010

Controlled utility study results of BGM Galectin-3 test for heart failure published in cardiology journal

BG Medicine, Inc. announced today that the results of a controlled study on the utility of its galectin-3 test in heart failure were published in the Journal Clinical Research in Cardiology, a peer-reviewed, international journal that publishes original research and review articles on clinical research studies in the field of cardiology.

17 Feb 2010

Majority of Americans support conservation, but few practice it in everyday lives

Most Americans like the idea of conservation, but few practice it in their everyday lives, according to the results of a national survey released today by researchers at Yale and George Mason universities.

17 Feb 2010

Amgen and Centocor Ortho Biotech Products: FDA approves REMS for Aranesp, EPOGEN and PROCRIT ESAs

Amgen Inc. and Centocor Ortho Biotech Products, L.P., today announced that the U.S. Food and Drug Administration (FDA) has approved the Risk Evaluation and Mitigation Strategy (REMS) for erythropoiesis-stimulating agents (ESAs), which include Aranesp® (darbepoetin alfa), EPOGEN® (Epoetin alfa) and PROCRIT® (Epoetin alfa).

17 Feb 2010

FDA extends CombinatoRx' Exalgo tablets NDA PDUFA review date

CombinatoRx, Incorporated today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for review of the Exalgo™ (hydromorphone HCl) extended-release tablets New Drug Application (NDA) from Monday, February 22, 2010 to Monday, March 1, 2010 due to federal government closings.

16 Feb 2010

Adding rosemary extracts in ground beef can reduce cancer-causing agents

The addition of rosemary extract to ground beef actually reduces cancer-causing agents that can form upon cooking, according to a recent study in the Journal of Food Science, published by the Institute of Food Technologists.

16 Feb 2010

Fourth-quarter and full-year 2009 results announced by Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders, today announced financial and operational results for the fourth quarter and full year ended December 31, 2009.

16 Feb 2010

Food News and Research

Effectiveness of influenza vaccines in older people: No clear conclusions

U.S. decreases troop presence in Haiti

Covidien's Exalgo NDA: FDA sets new PDUFA action date

Covidien, IAE POLATOM announce agreement to augment supply of Mo 99 to produce Tc 99m

FDA approves risk management program on ESA's for treating anemia due to chemotherapy

NASBE selects four states to receive grants to fight childhood obesity in their public schools

Iowa State University researchers awarded 30 ARRA grants worth $16.38M

New report focuses on how to reduce and control hypertension

In naming Islamic Conference Envoy, Obama highlights global health, food security efforts

USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection

Calypso real-time tumor tracking system usage during IMRT for prostate cancer reduces rectal/urinary side effects

High-fat ketogenic diet safe and effective for controlling childhood seizures

Generx clinical development opportunities: bioRASI to assist Cardium

Rhubarb may have anti-cancer properties, but more research needed

Controlled utility study results of BGM Galectin-3 test for heart failure published in cardiology journal

Majority of Americans support conservation, but few practice it in everyday lives

Amgen and Centocor Ortho Biotech Products: FDA approves REMS for Aranesp, EPOGEN and PROCRIT ESAs

FDA extends CombinatoRx' Exalgo tablets NDA PDUFA review date

Adding rosemary extracts in ground beef can reduce cancer-causing agents

Fourth-quarter and full-year 2009 results announced by Vanda Pharmaceuticals

The future is bioengineered: Synthetic biology and global sustainability eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News